NCT07127055 is a NA clinical trial of No intervention in Metabolic Syndrome, sponsored by University of Lahore.

Who is sponsoring NCT07127055?

NCT07127055 is sponsored by University of Lahore.

What drugs are being tested in NCT07127055?

Interventions in NCT07127055: No intervention, gluten free diet.

What condition does NCT07127055 study?

NCT07127055 studies Metabolic Syndrome, Lipid Profile, HOMA-IR, Weight Change, Body.

Is NCT07127055 still recruiting?

NCT07127055 is currently completed. Last updated 17 August 2025.

Last reviewed 2025-08-17 · How we verify

NCT07127055

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gluten Free Diet on Metabolic Syndrome

Completed NA Last updated 17 August 2025

What this trial tests

NA trial testing No intervention in Metabolic Syndrome in 108 participants. Completed in 10 April 2025.

Timeline

10 January 2025

Primary endpoint
10 April 2025

10 April 2025

Quick facts

Lead sponsor	University of Lahore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	108
Start date	10 January 2025
Primary completion	10 April 2025
Estimated completion	10 April 2025
Sites	1 location across Pakistan

Drugs / interventions tested

No intervention
gluten free diet

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →
Lipid Profile — all drugs for Lipid Profile →
HOMA-IR — all drugs for HOMA-IR →
Weight Change, Body — all drugs for Weight Change, Body →

Sponsor

University of Lahore

Who can join

Adults 30 to 55, any sex, with Metabolic Syndrome or Lipid Profile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study benefits the community by highlighting the potential of a gluten-free diet as a non-pharmacological, effective approach to managing obesity and type 2 diabetes. By demonstrating significant improvements in weight, blood sugar, lipid levels, and liver function, it supports dietary modification as a practical approach to enhancing metabolic health. The findings can inform public health initiatives, raise community awareness about the role of nutrition in disease management, and promote personalized dietary interventions, ultimately contributing to better prevention and control of chronic metabolic conditions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Modulation of metabolic parameters among obese diabetic individuals through a gluten-free diet.
Naeem F, Noreen S, Sultan H, Aja PM. · · 2026 · PMID 42010674 · DOI 10.1186/s40795-026-01316-1

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting

Other University of Lahore trials

Trials by the same sponsor.

NCT07420244 — Task-oriented Training Versus Group Circuit Training in Children With Quadriplegic Cerebral Palsy · NA · not yet recruiting
NCT07446218 — Pharmacist-led Interventions in Psychiatric Patients · NA · not yet recruiting
NCT07359378 — Progressive Resistance Exercise Versus Functional Training in Elderly With Risk of Fall. · NA · not yet recruiting
NCT07244913 — Therapeutic Effects of Instrument-assisted Versus Sound-assisted Soft Tissue Mobilization in Chronic Non-specific Low Ba · NA · recruiting
NCT07436624 — Kabat Rehabilitation Versus Kinesiology Taping in Bell's Palsy · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07127055 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Lahore
Last refreshed: 17 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07127055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing